Every patient presented with palmar hyperhidrosis alone (10 patients, 18 .5%) or with additional affected areas ( Table 1) . Twenty-one patients (38.9%) had a family history of hyperhidrosis. Hyperhidrosis was a lifelong condition in 43 patients (79.6%). Its onset was in childhood in 2 patients (3.7%) and in puberty in 9 patients (16.7%).
Each patient had undergone at least one failed nonsurgical treatment. The mean number of nonoperative treatments was 1.7 (range 1-4). Drysol (Person & Covey, Inc.), Drionic (General Medical Co.), botulinum toxin A injections, and prescribed medications, such as propranolol, clonidine, or anticholinergic agents were the most common nonsurgical treatments. No patient had undergone previous surgical treatment for hyperhidrosis.
Surgical Technique
The surgical technique has been previously described. 11 Briefly, the patient is intubated with a doublelumen endotracheal tube. Correct positioning of the endotracheal tube is bronchoscopically confirmed by the anesthesiologist. Palmar cutaneous temperature monitors (Mallinckrodt, Inc.) are applied bilaterally. The patient is placed in a lateral decubitus position on a beanbag and taped securely to the bed over the pelvis and shoulder (Fig. 1) . The ipsilateral lung is deflated by the anesthesiologist using a double-lumen endotracheal tube. Two 5-mm incisions are made after the skin is injected with 0.5% bupivacaine with epinephrine.
The endoscope is inserted in the fifth intercostal space in the posterior axillary line. The working portal (for the cautery scissors and chest tube) is placed in the middle or anterior axillary line in the third intercostal space. A 6-mm-diameter trocar and stylette are inserted through the first incision for the 5-mm thoracoscope (Karl Storz Endoscopy-America, Inc.), which is inserted into the chest cavity. Under direct endoscopic observation, a hemostat is placed through the inner pleura at the second portal site. The second 5-mm portal is placed in the chest under endoscopic observation. Endoscopic mono polar cautery scissors are inserted through the second portal. The patient is rotated ventrally until gravity retracts the lung sufficiently away from the surface of the spine so that the rib heads and sympathetic chain are identified. The second rib is identified at its articulation with the spine.
The extent of sympathectomy is dictated by the patient's symptoms and has evolved across the case series. Early in the series (first 14 cases), we resected the sympathetic chain from T-2 to T-4 or T-5. We then adopted a policy of tailored chain division over the rib head (sympathotomy) guided by the patient's preoperative symptoms (presence or absence of axillary hyperhidrosis) and by intraoperative palmar temperature monitoring. The sympathetic chain is tented laterally and transected with cauterization to create a gap of 5 mm or more between the ends of the sympathetic chain. That is, a T-2 sympathectomy is performed by dividing the chain (sympathotomy) over the second and third rib heads. Care is taken to preserve the surrounding vascular structures. After the sympathetic chain is transected, the surrounding soft tissue is inspected to confirm complete transection and to search for accessory sympathetic nerves (nerves of Kuntz).
The anesthesiologist records palmar temperatures during the procedure. A temperature increase of 1°C is commonly thought to confirm adequate sympathectomy. 12 When the working portals are removed, a 20 Fr chest tube is inserted through the vacated hole. Reinflation of the lung is observed directly before the thoracoscope is removed from the chest cavity. The 2 incision sites are closed in a standard fashion.
The chest tube is kept in the first side and placed for suction until the contralateral sympathectomy is completed. The patient is repositioned, and the sympathectomy on the contralateral side is performed using identical techniques. At the conclusion of the second sympathectomy both chest tubes are removed. A sitting anteroposterior plain chest radiograph is obtained to confirm the absence of significant residual pneumothoraces.
Postoperatively, all patients used an incentive spirometer and were treated with narcotic analgesic medication for 48-72 hours. At the beginning of the series (in the first 16 cases), patients were typically discharged the next morning. Most patients were then discharged a few hours after surgery. Patients were permitted to return to normal activity 3-7 days after surgery.
Results
Blood loss was listed as "minimal" in all 54 operative reports. The sympathetic chain was divided successfully in all cases. All chest tubes were removed in the operating room, and no patient had a significant residual pneumothorax demonstrated on chest radiograph.
Surgical Outcomes
Surgical outcomes at last follow-up were evaluated according to region of preoperative hyperhidrosis (Fig. 2) . Hyperhidrosis was completely alleviated at rates of 98.1%, 70.4%, and 13.2% in palmar, axillary, and plantar locations, respectively. Combining resolution and improvement yielded rates of 100%, 96.3%, and 71.1% for palmar, axillary, and plantar locations. In 1 patient (3.7%), axillary hyperhidrosis failed to improve. No patients' axillary hyperhidrosis worsened. Plantar hyperhidrosis remained unchanged in 10 patients (26.3%) and worsened in 1 patient (2.6%). There were no recurrences of hyperhidrosis at last follow-up. No patient reported gustatory sweating.
Hospital length of stay averaged 0.37 days. Thirtyseven patients (68.5%) were discharged the day of surgery. Since the overnight stay policy was abandoned, 4 of 38 patients required admission to the hospital (3 for pain control, 1 for evaluation of arrhythmia).
Complications were limited to 1 case in which the patient experienced intraoperative asystole requiring cardioversion to restore rhythm during the left side of a bilateral T2-4 sympathectomy. The procedure on the right side, which was treated before the left, was completed uneventfully. The patient had no predisposing factors and an exhaustive evaluation revealed no abnormalities. She required a 2-day hospital stay for evaluation and suffered no permanent morbidity. Her palmar and axillary hyperhidrosis resolved completely. No patient experienced a wound infection, pneumothorax, persistent pain, pneumonia, vascular injury, Horner syndrome, or recurrence.
Thirty patients (54.3%) reported compensatory sweating, a known side-effect of thoracoscopic sympathectomy. Two patients described the compensatory sweating as "severe, bothersome," and 28 patients described it as "mild/ moderate, nonbothersome." Chi-square analysis of individual levels of sympathectomy showed no significant relationship between compensatory sweating and levels of transection (p = 0.0640). When T-5 sympathectomy was included in the analysis, however, the frequency of bothersome compensatory sweating tended to increase (Fig. 3) .
When patients were asked if they were satisfied with their surgical outcome and would undergo the same operation again, 53 patients (98.1%) responded "yes." The only exception was the patient who experienced the intraoperative asystole.
Discussion
Hyperhidrosis can be disabling to patients in general and can be especially distressing to adolescents who are developing their self-image, social networks, and selfesteem. Adolescents are affected by hyperhidrosis to various degrees and formalized rating scales exist; however, we find the clinical interview and examination to be more useful in determining who will benefit from this procedure. 3 Patients with severe symptoms often report that sweat spontaneously drips from their hands making activities such as schoolwork, sports, and social interactions embarrassing, uncomfortable, and, in some cases, impossible. It is this group of patients, with severe symptoms, that are offered sympathectomy. Prompt, effective, safe treatment can remove an obstacle that can negatively affect their maturation into adulthood and their ability to function normally and productively in society.
Medical treatments tend to be ineffective and to have significant side effects. They often provide only modest or temporary symptomatic relief. 2, 7, 9, 19, 21 In reports that have focused on adolescents, thoracoscopic sympathectomy has been relatively safe and effective (98% complete remission) and associated with few recurrences. 5, 6, 17 There is also evidence that younger patients are less inclined to suffer compensatory sweating and more likely to be satisfied with their surgical outcome than older patients. 17 Numerous reports have documented the safety and efficacy of this procedure in adults. Based on the excellent effectiveness and low risk of this procedure, we recommend early surgical treatment when medical therapy fails to improve severe symptoms.
Compensatory sweating remains the most challenging side effect of this procedure. Adults undergoing sympathectomy for palmar hyperhidrosis report compensatory sweating 12%-100% of the time; however, fewer than 10% regret undergoing the procedure. 21 Younger patients report less compensatory sweating and a higher satisfaction rate than do older adolescents and adults (69.8% and 92.2% vs 88.5% and 80.7%, respectively). 17 We chose to perform chain resections early in the case series and refined the procedure to a tailored selection of sympathotomy levels based on preoperative symptoms and clues from intraoperative palmar temperature. Several attempts have been made to determine the optimal transaction strategy to reduce the incidence of compensatory sweating while maintaining the high palmar hyperhidrosis remission rate in adults. 4, 13, 15 There is no consensus about which levels are most appropriate to section.
One of our patients experienced intraoperative asystole that required cardioversion. Most patients experience bradycardia after sympathectomy, and vagal tone is increased once the ganglia have been disconnected. 8 Lin et al.
14 reported 2 similar cases during a left T2-3 sympathetic chain transection. Both patients required cardiopulmonary resuscitation and recovered completely without complications. They postulated that continuous stimulation to the left stellate ganglion immediately before transection stimulates cardiac arrest. One case of delayed asystole has also been reported. 16 In all previously reported cases of asystole, as well as in our case, the patients recovered without sequelae.
The anesthesiologist in our case hypothesizes that paralytic reversal performed by instilling glycopyrrolate mixed in the same syringe with neostigmine in conjunction with sympathetic denervation was responsible for the asystole. He now separately administers the glycopyrrolate followed by neostigmine. This phenomenon underscores the importance of vigilant intraoperative monitoring of the cardiac rhythm by the anesthesiologist and adequate preparation to deal with complications should they arise.
Conclusions
Thoracoscopic sympathectomy is safe, efficient, and effective for the relief of palmar hyperhidrosis in adolescents. Axillary hyperhidrosis and, to some extent, plantar hyperhidrosis also may be relieved. Recurrences are rare. Because the procedure is minimally invasive, pain and complications are minimized. Compensatory sweating can be expected in about half of the patients who undergo this procedure.
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